Clinical Trials Directory

Trials / Completed

CompletedNCT00248768

Accelerated Transcranial Magnetic Stimulation (TMS) for Depression

Accelerated Transcranial Magnetic Stimulation for Depression

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
20 (actual)
Sponsor
US Department of Veterans Affairs · Federal
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determinate if accelerated rTMS treatment over 1.5 days is effective for ameliorating depression in Parkinson's disease.

Detailed description

Objective: The goal of this study is to investigate a new approach to administering repetitive transcranial magnetic stimulation (rTMS) in patients with refractory depression. (Please Note: The original requirement for comorbid Parkinson's disease has been dropped from this study). Research Plan: This inpatient study will provide an initial test for the hypothesis that accelerated rTMS is an effective treatment for depression. Followup testing will help delineate the time course of response. Methods: The rTMS treatment site over left dorsolateral prefrontal cortex will be 5.5cm anterior to the hand motor area. Treatments consisting of 1000 total pulses at 10 Hz and 100% motor threshold will be administered hourly for 1.5 days, totaling 15 sessions. A comprehensive test battery will be administered just before and after treatment, at 3 weeks, and at 6 weeks after treatment. Clinical Relevance: We expect that accelerated rTMS treatments will lessen the degree of depression to the same extent as rTMS treatments of longer duration, but far more rapidly. A much shorter hospitalization would be more easily tolerated. In addition, reducing the duration of hospitalization substantially reduces burdens and costs to hospital, staff, and caregivers, while more rapidly enhancing function and quality of life.

Conditions

Interventions

TypeNameDescription
DEVICETranscranial magnetic Stimulatora device which produces intense magnetic fields in the brain and activates cerebral neurons

Timeline

Start date
2005-02-01
Primary completion
2009-01-01
Completion
2009-06-01
First posted
2005-11-04
Last updated
2014-09-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00248768. Inclusion in this directory is not an endorsement.